Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
about
Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouseCD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.Acute clearance of human metapneumovirus occurs independently of natural killer cells.Immunity to RSV in Early-Life.Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathologyCo-immunization of plasmid DNA encoding IL-12 and IL-18 with Bacillus Calmette-Guérin vaccine against progressive tuberculosisNK cells: immune cross-talk and therapeutic implications.Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection.Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients.Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system.Respiratory syncytial virus infection: an innate perspective.Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.Respiratory syncytial virus--a comprehensive review.Natural killer cells in asthmaA Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus DiseaseRole of γδ T cells in exacerbated airway inflammation during reinfection of neonatally primed mice in adulthood.NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice.Critical role of natural killer cells in lung immunopathology during influenza infection in mice.Activation and Role of NACHT, LRR, and PYD Domains-Containing Protein 3 Inflammasome in RNA Viral Infection.Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine.
P2860
Q30417443-5E97470C-54DF-4BD4-90F4-D818182FE298Q33826900-245B1E65-8C06-4694-8AF7-F691826B1457Q34043293-D1F47C15-B095-4E77-A933-DA53CB2138A7Q34055489-F756B404-2273-451D-B3D6-602986DC8DF5Q34059593-37646E53-49B8-4793-95A2-27725A7BAE78Q34262084-9CDB5023-F9B4-4047-8BA9-703A10F0342CQ34264615-68FFF32E-E53E-4E16-835C-27384CBEEB9CQ34550454-C56F79A4-BE6E-4E9C-BBE9-714EECAC010FQ35099663-282C0F3E-6887-4450-931B-99DA40CFC5A9Q35561894-AC38E65D-0D38-4719-8626-62FFF716131AQ35591444-AB8A3ADE-B942-4761-92E5-A309EB68142FQ35765491-610ED0C8-160B-418E-89CF-7A3080DB9E31Q35826605-1F9E50D6-BB4E-46E3-8619-9ED41CE2DD86Q35913930-836A7DB7-09CE-4172-BB97-76F1071E936FQ36207088-A50320F4-ADFD-461E-9DDE-FE6ADEBDDFCBQ36276582-98E51A70-F426-4143-BB4D-D57199C4BC06Q37547808-0694BED2-B83B-4782-BB7A-D87E08BC071AQ37577700-6A2A3785-1529-41C7-B577-4369D886F238Q37698331-EEF724C0-D87C-410C-B46C-EB75C440B74DQ38098094-B4BAF528-F2AC-48A9-84CD-E4F855CB0345Q38117142-0767BF75-223B-485F-887C-E7067D575210Q38797620-7BA45A37-D4EC-45E6-AC8F-D028E95EC4C1Q40080338-E665ED4F-0015-479C-BD0C-27C2E7C11DFFQ40689054-990365B5-C3C4-4E2A-A547-49FB509699FDQ45195586-CD39ACDE-9977-4769-AE59-C51E2C02947EQ47127817-6CDA192A-34C6-407C-9BA3-FAF4E4917D5EQ49296005-E2FCD983-F548-47D5-A8B7-C7619E946029
P2860
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin 18 coexpression du ...... iated by natural killer cells.
@ast
Interleukin 18 coexpression du ...... iated by natural killer cells.
@en
type
label
Interleukin 18 coexpression du ...... iated by natural killer cells.
@ast
Interleukin 18 coexpression du ...... iated by natural killer cells.
@en
prefLabel
Interleukin 18 coexpression du ...... iated by natural killer cells.
@ast
Interleukin 18 coexpression du ...... iated by natural killer cells.
@en
P2093
P2860
P50
P356
P1433
P1476
Interleukin 18 coexpression du ...... iated by natural killer cells.
@en
P2093
Alexander Bukreyev
Alexandra Godlee
Debbie C P Lee
Devika Sawant
Jennifer L Wahlsten
Lucy G Thorne
Peter J M Openshaw
Peter L Collins
P2860
P304
P356
10.1128/JVI.02014-09
P577
2010-02-03T00:00:00Z